Document:

EX-10.45

 Exhibit 10.45 

AMENDMENT NO. 1 TO 

PAY-FOR-CALL DISTRIBUTION AGREEMENT 

This Amendment No. 1 (“Amendment”), effective as of December 31, 2012 (the “Amendment Effective
Date”), is being entered into by and between Marchex Sales LLC, a Delaware limited liability company and successor in interest to Marchex Sales, Inc., which is a wholly-owned subsidiary of Marchex, Inc. (“Marchex”), and
YellowPages.com LLC, a Delaware limited liability company formerly doing business as AT&T Interactive or ATTi (“YP”), to amend the Pay-For-Call Distribution Agreement entered between YP and Marchex effective as of
January 1, 2011 (the “Agreement”). YP and Marchex may hereinafter be referred to individually as “Party” and collectively as “Parties.” Capitalized terms used herein but
not defined shall have the respective meanings ascribed to them in the Agreement. 
 WHEREAS, Marchex provides certain pay-for-call
advertising services to YP pursuant to the terms of the Agreement; and 
 WHEREAS, the Parties desire to extend the term and amend
certain provisions of the Agreement; 
 NOW, THEREFORE, in consideration of the mutual acknowledgements and agreements hereinafter
contained, including to be legally bound, the Parties agree as follows: 
  

	 	1.	Campaign Summary. The Campaign Summary following the Agreement preamble is hereby deleted and not replaced. 

  

	 	2.	Section 2.3 — Determination of Marchex Network. Section 2.3 of the Agreement is hereby deleted and replaced with the following language: 

“2.3 Determination of Marchex Network. Marchex will have the right to determine which sites and applications in the Marchex
Network will display the YP SEM Product Listings, and Marchex does not guarantee inclusion of the YP SEM Product Listings within the published results of any particular Distribution Partner Channel. For the avoidance of doubt, in its sole
professional discretion, Marchex shall determine the composition of the Marchex Network. *** 

  
  

	[***]	Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 ***. 
  

	 	3.	Fees - Section 4.1 (a): At the end of the Section 4.1(a), the following text shall be added, without changing any of the prior text of the subsection: 

“As of July 1, 2013 and for periods thereafter during the Term, in connection with the foregoing programs, (i) the Charged Call
Fee shall be $***, or such other rate as mutually agreed upon in writing by the Parties, for each Qualifying Call, and (ii) a Qualifying Call shall be each call a User places to a Call Tracking Number where: ***. 

 

	 	4.	Fees - Section 4.1 (b): Subsection 4.1(b) is hereby deleted and replaced as follows: 

“(b) As of July 1, 2013 and for periods thereafter during the Term, for each calendar billing month, YP shall be obligated to meet a
minimum spend commitment (the “Minimum Monthly Payment Obligation”) equal to the greater of: ***. For the avoidance of doubt, YP will be obligated to pay no less than the Minimum Monthly Payment Obligation or the
actual higher amount based on delivery and applicable rates in such calendar billing month. *** 

  
  

	[***]	Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

 ***. 
  

	 	5.	Term - Section 7.1. In accordance with the language in Section 7.1 of the Agreement, the Parties hereby agree to reinstate and renew the Agreement through and including June 30, 2015. Thus,
unless otherwise terminated in accordance with the terms of the Agreement, the Agreement shall continue in full force and effect through and including June 30, 2015. The Parties agree that for all purposes they will treat the Agreement as if it
did not expire. 

 6. Termination - Section 7.4. Section 7.4 is hereby deleted in its entirety and replaced as
follows: 
 “7.4. No Termination for Convenience. Neither Party shall have the right to terminate this Agreement for convenience
and such Agreement shall continue in effect through June 30, 2015, unless terminated earlier for cause or bankruptcy pursuant to the express terms of Sections 7.2 or 7.3.” 

 

	 	7.	Party References. All references to ATTi or AT&T Interactive in the Agreement shall be replaced with or deemed to refer to YP. 

 

	 	8.	Email Addresses. All email addresses for YP in the agreement that specify the domain name “@attinteractive.com” shall be changed to the domain name “@yp.com”. 

 

	 	9.	Other Terms of the Agreement. All other terms and conditions of the Agreement shall remain unchanged and in full force and effect. 

 

	 	10.	Authority. Each person signing this Amendment hereby represents and warrants that he or she has full authority to execute this Amendment for the Party on whose behalf he or she is signing. 

  
 3 

 

	[***]	Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. 

	 	11.	Counterparts. This Amendment may be executed in one or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. A signature received
electronically via facsimile or email shall be as legally binding for all purposes as an original signature. 

 IN WITNESS WHEREOF, the
Parties have executed this Amendment No. 1 to Pay for Call Distribution Agreement effective as of the Amendment Effective Date. 
  

									
	 YELLOWPAGES.COM LLC
	  		  	MARCHEX SALES LLC
					
	By:	 	 /s/ Mark W. Smith
	  		  	By:	  	 /s/ Brendhan Hight

	Name: Mark W. Smith	  		  	Name: Brendhan Hight
	Title: CFO	  		  	Title: Director
			
	Date: 7/26/2013	  		  	Date: July 26, 2013

  

	[***]	Certain information in this agreement has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Ex. 10.196 - Supplemental Indenture re 7% Notes due 2019 (DAVA Guarantee...

Exhibit 10.196

EXECUTION VERSION

SUPPLEMENTAL INDENTURE
SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of August 11, 2014, among DAVA Pharmaceuticals, Inc. (the “Guaranteeing Subsidiary”), a Delaware corporation and subsidiary of Endo Limited, a private limited company incorporated under the laws of Ireland (the “Company”), the Issuers, the other Guarantors (both, as defined in the Indenture referred to below) and Wells Fargo Bank, National Association, as trustee under the Indenture referred to below (the “Trustee”).
W I T N E S S E T H
WHEREAS, Endo Finance LLC, a Delaware limited liability company, and Endo Finco Inc., a Delaware corporation, have heretofore executed and delivered to the Trustee an indenture, dated as of May 6, 2014, as supplemented by a supplemental indenture, dated as of May 28, 2014, and a supplemental indenture, dated as of July 10, 2014, in each case, among the Issuers, the Guarantors party thereto and the Trustee (as so supplemented, the “Indenture”), providing for the issuance of 7.00% Senior Notes due 2019 (the “Notes”);
WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Issuers’ Obligations under the Notes and the Indenture on the terms and conditions set forth herein (the “Note Guarantee”); 
WHEREAS, this Supplemental Indenture has not resulted in a material modification of the Notes for Foreign Account Tax Compliance Act purposes; and
WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.
NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Guaranteeing Subsidiary and the Trustee mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows:
1.    CAPITALIZED TERMS.  Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
2.    AGREEMENT TO GUARANTEE.  The Guaranteeing Subsidiary hereby agrees to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the Note Guarantee and in the Indenture including but not limited to Article 10 thereof.
4.    NO RECOURSE AGAINST OTHERS.  No director, officer, employee, incorporator or stockholder of the Issuers or any Guarantor, as such, will have any liability for any obligations of the Issuers or the Guarantors under the Notes, the Indenture, this Supplemental Indenture, the Note Guarantees or for any claim based on, in respect of, or by reason of, such obligations or their creation.  Each Holder of Notes by accepting a Note waives and releases all such liability.  The waiver and release are part of the consideration for issuance of the Notes.  The waiver may not be effective to waive liabilities under the federal securities laws.

Exhibit 10.196

5.    NEW YORK LAW TO GOVERN; WAIVER OF JURY TRIAL.  THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.  EACH OF THE ISSUERS AND THE GUARANTORS CONSENTS AND IRREVOCABLY SUBMITS TO THE JURISDICTION OF ANY NEW YORK STATE OR U.S. FEDERAL COURT LOCATED IN THE BOROUGH OF MANHATTAN, CITY OF NEW YORK, COUNTY OF NEW YORK, STATE OF NEW YORK IN RELATION TO ANY LEGAL ACTION OR PROCEEDING (I) ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS INDENTURE, AS SUPPLEMENTED, THE NOTES, THE GUARANTEES AND ANY RELATED DOCUMENTS AND/OR (II) ARISING UNDER ANY U.S. FEDERAL OR U.S. STATE SECURITIES LAWS IN RESPECT OF THE NOTES, THE GUARANTEES AND ANY SECURITIES ISSUED PURSUANT TO THE TERMS OF THE INDENTURE, AS SUPPLEMENTED.  EACH OF THE ISSUERS AND THE GUARANTORS WAIVES ANY OBJECTION TO PROCEEDINGS IN ANY SUCH COURTS, WHETHER ON THE GROUND OF VENUE OR ON THE GROUND THAT THE PROCEEDINGS HAVE BEEN BROUGHT IN AN INCONVENIENT FORUM.  EACH OF THE ISSUERS AND THE GUARANTORS, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, SHALL APPOINT CT CORPORATION SYSTEM, 111 EIGHTH AVENUE, 13TH FLOOR, NEW YORK, NY 10011, AS ITS AGENT FOR SERVICE OF PROCESS IN ANY SUCH SUIT, ACTION OR PROCEEDING AND AGREES THAT SERVICE OF PROCESS UPON SAID AUTHORIZED AGENT SHALL BE DEEMED IN EVERY RESPECT EFFECTIVE SERVICE OF PROCESS UPON IT IN ANY SUCH SUIT, ACTION OR PROCEEDING. EACH OF THE ISSUERS AND THE GUARANTORS AGREES TO DELIVER, UPON THE EXECUTION AND DELIVERY OF THIS SUPPLEMENTAL INDENTURE, A WRITTEN ACCEPTANCE BY SUCH AGENT OF ITS APPOINTMENT AS SUCH AGENT. EACH OF THE ISSUERS AND THE GUARANTORS, TO THE EXTENT ORGANIZED OUTSIDE OF THE UNITED STATES, FURTHER AGREES TO TAKE ANY AND ALL ACTION, INCLUDING THE FILING OF ANY AND ALL SUCH DOCUMENTS AND INSTRUMENTS, AS MAY BE REASONABLY NECESSARY TO CONTINUE SUCH DESIGNATION AND APPOINTMENT OF CT CORPORATION SYSTEM IN FULL FORCE AND EFFECT FOR SO LONG AS THE INDENTURE, AS SUPPLEMENTED, REMAINS IN FORCE.  EACH OF THE ISSUERS, THE TRUSTEE AND THE GUARANTORS HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.
6.    COUNTERPARTS.  The parties may sign any number of copies of this Supplemental Indenture.  Each signed copy (which may be provided via facsimile or other electronic transmission) shall be an original, but all of them together represent the same agreement.  
7.    EFFECT OF HEADINGS.  The Section headings herein are for convenience only and shall not affect the construction hereof.
8.    THE TRUSTEE.  The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary and the Issuers.

Exhibit 10.196

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed and attested, all as of the date first above written.

 
	
		
	DAVA PHARMACEUTICALS, INC., as

	Guaranteeing Subsidiary

	
		
	By:
	/s/ Deanna Voss

	 
	Name: Deanna Voss 

	 
	Title: Assistant Secretary

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
		
	ENDO FINANCE LLC

	  as an Issuer

	    by ENDO LUXEMBOURG FINANCECOMPANY I

	        S.À R.L., its sole member

	
		
	By:
	/s/ Andrew O’Shea

	Name:
	Andrew O’Shea

	Title:
	B Manager

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
		
	ENDO FINCO INC.

	   as an Issuer

	
		
	By:
	/s/ Deanna Voss

	 
	Name: Deanna Voss 

	 
	Title: Secretary

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
		
	ENDO LLC

	  ENDO U.S. INC.

	    each, as a Guarantor

	
		
	By:
	/s/ Deanna Voss

	Name:
	Deanna Voss

	Title:
	Secretary

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	ENDO HEALTH SOLUTIONS INC.

	ENDO PHARMACEUTICALS INC.

	ENDO PHARMACEUTICALS SOLUTIONS INC.

	ENDO PHARMACEUTICALS VALERA INC

	GENERICS INTERNATIONAL (US PARENT), INC.

	GENERICS INTERNATIONAL (US MIDCO), INC.

	GENERICS INTERNATIONAL (US HOLDCO), INC.

	GENERICS INTERNATIONAL (US), INC.

	AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.

	AMERICAN MEDICAL SYSTEMS, INC.

	AMS RESEARCH CORPORATION

	AMS SALES CORPORATION

	LASERSCOPE 

	   each, as a Guarantor

	
		
	By:
	/s/ Deanna Voss

	Name:
	Deanna Voss

	Title:
	Assistant Secretary

 

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	GENERICS BIDCO I, LLC 

	VINTAGE PHARMACEUTICALS, LLC 

	GENERICS BIDCO II, LLC

	MOORES MILL PROPERTIES LLC

	WOOD PARK PROPERTIES LLC 

	QUARTZ SPECIALTY PHARMACEUTICALS, LLC

	   each, as a Guarantor

	   by GENERICS INTERNATIONAL (US), INC., 

	   its manager

	
		
	By:
	/s/ Deanna Voss

	Name:
	Deanna Voss

	Title:
	Assistant Secretary

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	LEDGEMONT ROYALTY SUB LLC

	   as a Guarantor

	   by ENDO PHARMACEUTICALS SOLUTIONS INC.,

	   its manager

	
		
	By:
	/s/ Deanna Voss

	Name:
	Deanna Voss

	Title:
	Assistant Secretary

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	ENDO LIMITED

	   as a Guarantor

	
		
	By:
	 /s/ Jack Boyle

	 
	Name: Jack Boyle

	 
	Title: Attorney

	
	
	ENDO VENTURES LIMITED

	   as a Guarantor

	
		
	By:
	 /s/ Jack Boyle

	 
	Name: Jack Boyle

	 
	Title: Attorney

	
	
	ENDO MANAGEMENT LIMITED

	   as a Guarantor

	
		
	By:
	 /s/ Jack Boyle

	 
	Name: Jack Boyle

	 
	Title: Attorney

	
	
	ENDO FINANCE LIMITED

	   as a Guarantor

	
		
	By:
	 /s/ Jack Boyle

	 
	Name: Jack Boyle

	 
	Title: Attorney

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	ENDO LUXEMBOURG HOLDING COMPANY S.À R.L. 

	   as a Guarantor

	
		
	By:
	 /s/ Andrew O' Shea

	Name:
	Andrew O' Shea

	Title:
	B Manager

	
	
	ENDO LUXEMBOURG FINANCE COMPANY S.À R.L. 

	   as a Guarantor

	
		
	By:
	 /s/ Andrew O' Shea

	Name:
	Andrew O' Shea

	Title:
	B Manager

	
	
	ENDO LUXEMBOURG FINANCE COMPANY S.À R.L. 

	   as a Guarantor

	
		
	By:
	 /s/ Andrew O' Shea

	Name:
	Andrew O' Shea

	Title:
	B Manager

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	PALADIN LABS CANADIAN HOLDING INC.

	   as a Guarantor

	
		
	By:
	/s/ Mark Beaudet

	Name:
	Mark Beaudet

	Title:
	President

	
	
	PALADIN LABS INC.

	   as a Guarantor

	
		
	By:
	/s/ Mark Beaudet

	Name:
	Mark Beaudet

	Title:
	President

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	ENDO VENTURES BERMUDA LIMITED, as a

	Guarantor

	
		
	By:
	/s/ Robert Rush    

	 
	Name: Robert Rush

	 
	Title:   Director

 
    

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	ENDO NETHERLANDS B.V., as a Guarantor

	
		
	By:
	/s/ Blaine T. Davis

	 
	Name: Blaine T. Davis

	 
	Title:   Managing Director A

	
		
	By:
	/s/ Gert Jan Rietberg

	 
	Name: Gert Jan Rietberg

	 
	Title:   Managing Director B

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Exhibit 10.196

	
	
	WELLS FARGO BANK, NATIONAL ASSOCIATION,

	as Trustee

	
		
	By:
	/s/ Martin Reed

	 
	Name: Martin Reed

	 
	Title:   Vice President

[Signature Page to 7.00% Senior Notes due 2019 Supplemental Indenture]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00237-of-00352.parquet"}]]